195 filings
Page 2 of 10
424B5
h02 qj5968sy31
8 Jun 23
Prospectus supplement for primary offering
4:01pm
8-K
6nmpb
7 Jun 23
Departure of Directors or Certain Officers
4:24pm
424B5
drige75db3qr1
6 Jun 23
Prospectus supplement for primary offering
5:22pm
8-K
kttt97s q2nrnr
6 Jun 23
Other Events
4:03pm
8-K
sxefa7 lt38iulzy6q
9 May 23
Cogent Biosciences Reports Recent Business Highlights and First Quarter
8:13am
ARS
1tmxx 3n794nb8
25 Apr 23
Annual report to shareholders
4:10pm
DEFA14A
rven2in
25 Apr 23
Additional proxy soliciting materials
4:06pm
S-8
xmxsm395fx33loa
14 Mar 23
Registration of securities for employees
4:02pm
8-K
2d4vp5uex1iqeupnt1
14 Mar 23
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
8:21am
S-3ASR
yrga6
10 Feb 23
Automatic shelf registration
4:57pm
8-K
3qy9n m0vif
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
8-K
zl9ao
14 Nov 22
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results
7:14am
8-K
nyt61t5sxtiudm
9 Aug 22
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results
7:15am
8-K/A
73amt9ie1r5b rp2
16 Jun 22
Entry into a Material Definitive Agreement
5:03pm
8-K
ju3wc7zbu1o6wloyl5rl
15 Jun 22
Entry into a Material Definitive Agreement
5:18pm